Clinical and Molecular Study of CHARGE Syndrom (NCT03186144) | Clinical Trial Compass
CompletedNot Applicable
Clinical and Molecular Study of CHARGE Syndrom
France141 participantsStarted 2012-02
Plain-language summary
1. Clinical description of a French cohort of patients with CHARGE syndrome.
2. Search any phenotype-genotype correlation in typical, atypical or incomplete form of the syndrome
3. Using Next generation Sequencing, try to identify other genes involved in this syndrome, as the CHD7 gene is involved in only 40-60% of cases
Who can participate
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria: Clinical criteria
Major criteria:
* Ocular coloboma
* Chonamal atresia and/or cleft palate
* Semi-CircularCanals hypoplasia
Minor criteria:
* Cranial nerves
* Hypothalamic-pituitary deficiency
* Internal or external ear malformation
* Cardiac, esophageal malformations
* Intellectual Deficiency
Diagnosis criteria:
* Typical CHARGE: 3 major criteria or 2 major + 2 minor
* Partial CHARGE: 2 major + 1 minor
* Atypical CHARGE: 2 major without minor or 1 major + 2 minor
Exclusion Criteria:
* Absent consentment for genetic analysis
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Description Clinical and molecular analysis of a French cohort CHARGE
Timeframe: 12 month
2
Execution of the socio-adaptive scale, parental scale
Timeframe: 12 month
3
Rate of mutations of CHD7 and / or type of mutations